Clinical significance of pyrimidine nucleoside phosphorylase in colorectal carcinoma

International Journal of Oncology

Volumn 10, Issue 3, 1997, Pages 493-496

  Mimori, Koshi ^a   Mori, Masaki ^a   Shiraishi, Takeshi ^a   Haraguchi, Masaru ^a   Ueo, Hiroaki ^a   Akiyoshi, Tsuyoshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

colorectal carcinoma; enzyme activity; pyrimidine nucleoside phosphorylase; reverse transcriptase polymerase chain reaction

Indexed keywords

PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROGNOSIS;

EID: 0030893655     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.10.3.493     Document Type: Article

References (17)

1. Cook AF, Holman MJ. Kramer MJ and Trown PW: Fluorinated pyrimidine nucleoside. 3. Synthesis and antitumor activity of a series of 5'-deoxy-5-fluoropyrimidine nuclcosides. J Med Chem 22: 1330-1335, 1979.
2. Eda H, Fujimoto K, Watanabe S, Ura M, Hino A, Tanaka Y, Wada K and Ishitsuka H: Cytokines induces thymidine phosphorylase expression in tumor cells and make them more susceptible to 5'-deoxy-5-fluorouridine. Cancer Chemother Pharmacol 32: 333-338, 1993.
3. Kono A, Hara Y, Sugata S, Karube Y, Matsushima Y and Ishitsuka H: Activation of 5'-deoxy-5-fluorouridine by thymidine phosphorylase in human tumors. Chem Pharm Bull Tokyo 31: 175-178, 1983.
4. Moran RG, Spears CP and Heidelberger C: Biochemical determinants of tumor sensitivity to 5-fluorouracil: ultrasensitive methods for the determination of 5-fluoro-2-deoxyuridate synthcase. Proc Natl Acad Sci USA 76: 1456-1460, 1979.
5. Ishikawa F, Miyazono K, Hellmen U, Drexler H, Wernstedt C, Hagiwara K, Uŝuki K, Takaku F, Risau W and Heldin CH: Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 338: 557-562, 1989.
6. Furukawa T, Yoshimura A, Sumizawa T, Haraguchi M and Akiyama S: Angiogenic factor. Nature 356: 668, 1992.
7. Nio Y, Kimura H, Tsubono M, Tseng CC, Kawabata K, Masai Y, Hayashi H, Meyer C, Fukumoto M and Tobe T: Antitumor activity of 5'-deoxy-5-fluorouridine in human digestive organ cancer xenografts and pyrimidine nucleoside phosphorylase activity in normal and neoplastic tissues from human digestive organs. Anticancer Res 12: 1141-1146, 1992.
8. Miwa M, Nishimura J, Kamiyama T and Ishitsuka H: Conversion of 5'-deoxyfluorouridine to 5-FU by pyrimidine nucleoside phosphorylases in normal and tumor tissues from rodents bearing tumors and cancer patients. Jpn J Cancer Chemother 14: 2924-2929, 1987.
9. Hirokoshi T, Danenberg KD, Stadbauer THW, Volkenandt M, Shea LCC, Aigner K, Gustavsson B, Leichman L, Frosing R, Ray M, Gibson NW, Spears CP and Dannanberg PV: Quantitation of thymidylate synthease, dihydrofolate reductase, and DT-diaphorase gene expression in human tumors using the polymerase chain reaction. Cancer Res 52: 108-116, 1992.
10. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol chloroform extraction. Anal Biochem 162: 156-159, 1987.
11. Mori M, Mimori K, Inoue H, Barnard GF, Tsuji K, Nanbara S, Ueo H and Akiyoshi T: Detection of cancer micrometastasis in lymph nodes by reverse transcription-polymerase chain reaction. Cancer Res 55: 3417-3420, 1995.
12. Williams S, Goddard J and Martin DJ: Human purine nucleoside phosphorylase cDNA sequence and genomic clone characterization. Nucleic Acids Res 12: 5779-5787, 1984.
13. Wang A, Doyle V and Mark D: Quantitation of mRNA by the polymerase chain reaction. Proc Natl Acad Sci USA 86: 9717-9721, 1989.
14. Luccioni C, Beaumatin J, Bardot V and Lafrancois D: Pyrimidine nucleotide metabolism in human colon carcinomas: comparison of normal tissues, primary tumors and xenografts. Int J Cancer 58: 517-522, 1994.
15. Miyadera K, Sumizawa T, Haraguchi M and Yoshida H: Role of thymidine phosphorylase activity in the angiogenic effect of platelet derived endothelial cell growth factor/thymidine phosphorylase. Cancer Res 55: 1687-1690, 1995.
16. Reynolds K, Farzaneh F, Collins W, Campbell S, Bourne T, Lawton F, Moghaddam A, Harris A and Bicknell R: Association of ovarian malignancy with expression of platelet-derived endothelial cell growth factor. J Natl Cancer Inst 86: 1234-1238, 1994.
17. Yoshimura S, Kuwazuru Y, Furukawa T, Yoshida H, Yamada K and Akiyama S: Purification and tissue distribution of human thymidine phosphorylase: high expression in lymphocytes, reticulocytes and tumors. Biochim Biophys Acta 1034: 107-113, 1990.